Bayer/Onyx Pharmaceuticals Stivarga (regorafenib) is approved for the treatment of GIST in the US, but a European filing in this indication is currently under review.
written on 27.06.2014
Bayer/Onyx Pharmaceuticals Stivarga (regorafenib) is approved for the treatment of GIST in the US, but a European filing in this indication is currently under review.
See our Cookie Privacy Policy Here